The Chemours Company (NYSE:CC) Insider Damian Gumpel Acquires 13,400 Shares

The Chemours Company (NYSE:CC - Get Free Report) insider Damian Gumpel purchased 13,400 shares of Chemours stock in a transaction that occurred on Monday, June 2nd. The shares were bought at an average price of $9.22 per share, with a total value of $123,548.00. Following the completion of the transaction, the insider now owns 123,879 shares of the company's stock, valued at $1,142,164.38. This represents a 12.13% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Damian Gumpel also recently made the following trade(s):

• On Tuesday, June 3rd, Damian Gumpel acquired 7,822 shares of Chemours stock. The shares were bought at an average cost of $9.95 per share, for a total transaction of $77,828.90.

Chemours Trading Up 4.1%

NYSE:CC traded up $0.44 on Friday, reaching $11.10. The stock had a trading volume of 4,103,485 shares, compared to its average volume of 2,214,869. The company has a market cap of $1.66 billion, a price-to-earnings ratio of 19.47 and a beta of 1.64. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92. The firm's fifty day moving average is $11.20 and its two-hundred day moving average is $15.31. The Chemours Company has a 12-month low of $9.13 and a 12-month high of $25.80.

Chemours (NYSE:CC - Get Free Report) last released its earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). The firm had revenue of $1.37 billion during the quarter, compared to analysts' expectations of $1.36 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%. Chemours's revenue for the quarter was up .4% on a year-over-year basis. During the same quarter last year, the company posted $0.32 earnings per share. Equities analysts expect that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Announces Dividend

The company also recently announced a dividend, which will be paid on Monday, June 16th. Shareholders of record on Monday, May 19th will be issued a $0.0875 dividend. The ex-dividend date of this dividend is Friday, May 16th. This represents a yield of 3.17%. Chemours's dividend payout ratio (DPR) is 175.00%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Strategic Financial Concepts LLC acquired a new stake in shares of Chemours in the fourth quarter worth approximately $357,000. Entropy Technologies LP acquired a new stake in shares of Chemours in the fourth quarter worth approximately $266,000. Sei Investments Co. boosted its position in shares of Chemours by 779.5% in the fourth quarter. Sei Investments Co. now owns 174,555 shares of the specialty chemicals company's stock worth $2,950,000 after acquiring an additional 154,709 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Chemours in the fourth quarter worth approximately $515,000. Finally, Victory Capital Management Inc. boosted its position in shares of Chemours by 6.8% in the fourth quarter. Victory Capital Management Inc. now owns 110,311 shares of the specialty chemicals company's stock worth $1,864,000 after acquiring an additional 7,052 shares during the last quarter. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CC has been the subject of several research analyst reports. Mizuho set a $15.00 target price on shares of Chemours in a research note on Tuesday, April 15th. Barclays dropped their price target on shares of Chemours from $16.00 to $13.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 28th. Wall Street Zen cut shares of Chemours from a "hold" rating to a "sell" rating in a research report on Wednesday, May 21st. UBS Group dropped their price target on shares of Chemours from $18.00 to $17.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Finally, The Goldman Sachs Group dropped their price target on shares of Chemours from $21.00 to $14.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Chemours currently has a consensus rating of "Hold" and a consensus target price of $17.22.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.